Alterations in neurotransmitter levels and transcription factor expression following intranasal buprenorphine administration

Buprenorphine is an opioid drug used in the management of pain and the treatment opioid addiction. Like other opioids, it is believed that it achieves these effects by altering functional neurotransmitter pathways and the expression of important transcription factors; cyclic AMP response element-bin...

Full description

Saved in:
Bibliographic Details
Published inBiomedicine & pharmacotherapy Vol. 138; p. 111515
Main Authors Xhakaza, Sanelisiwe P., Khoza, Leon J., Haripershad, Advaitaa M., Ghazi, Terisha, Dhani, Shanel, Mutsimhu, Cosmas, Molopa, Molopa J., Madurai, Nithia P., Madurai, Lorna, Singh, Sanil D., Gopal, Nirmala D., Kruger, Hendrik G., Govender, Thavendran, Chuturgoon, Anil, Naicker, Tricia, Baijnath, Sooraj
Format Journal Article
LanguageEnglish
Published France Elsevier Masson SAS 01.06.2021
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Buprenorphine is an opioid drug used in the management of pain and the treatment opioid addiction. Like other opioids, it is believed that it achieves these effects by altering functional neurotransmitter pathways and the expression of important transcription factors; cyclic AMP response element-binding protein (CREB) and brain-derived neurotrophic factor (BDNF) in the brain. However, there is a lack of scientific evidence to support these theories. This study investigated the pharmacodynamic effects of BUP administration by assessing neurotransmitter and molecular changes in the healthy rodent brain. Sprague-Dawley rats (150–200 g) were intranasally administered buprenorphine (0.3 mg/mL) and sacrificed at different time points: 0.25, 0.5, 1, 2, 4, 6, 8 and 24 h post drug administration. LC-MS was used to quantify BUP and neurotransmitters (GABA, GLUT, DA, NE and 5-HT) in the brain, while CREB and BDNF gene expression was determined using qPCR. Results showed that BUP reached a Cmax of 1.21 ± 0.0523 ng/mL after 2 h, with all neurotransmitters showing an increase in their concentration over time, with GABA, GLUT and NE reaching their maximum concentration after 8 h. DA and 5-HT reached their maximum concentrations at 1 h and 24 h, respectively post drug administration. Treatment with BUP resulted in significant upregulation in BDNF expression throughout the treatment period while CREB showed patterns of significant upregulation at 2 and 8 h, and downregulation at 1 and 6 h. This study contributes to the understanding of the pharmacodynamic effects of BUP in opioid addiction by proving that the drug significantly influences NT pathways that are implicated in opioid addiction. •The pharmacokinetics of BUP and its effects on neurotransmitters and the expression of CREB and BDNF were investigated.•BUP reached a Cmax 2 h post BUP administration with GABA, GLUT and NE reaching their maximum concentrations after 8 h.•DA and 5-HT peaked at 1 h and 8 h post-dose, respectively.•BUP significantly increased the expression of BDNF throughout the treatment period, while CREB showed variable expression.
AbstractList Buprenorphine is an opioid drug used in the management of pain and the treatment opioid addiction. Like other opioids, it is believed that it achieves these effects by altering functional neurotransmitter pathways and the expression of important transcription factors; cyclic AMP response element-binding protein (CREB) and brain-derived neurotrophic factor (BDNF) in the brain. However, there is a lack of scientific evidence to support these theories. This study investigated the pharmacodynamic effects of BUP administration by assessing neurotransmitter and molecular changes in the healthy rodent brain. Sprague-Dawley rats (150-200 g) were intranasally administered buprenorphine (0.3 mg/mL) and sacrificed at different time points: 0.25, 0.5, 1, 2, 4, 6, 8 and 24 h post drug administration. LC-MS was used to quantify BUP and neurotransmitters (GABA, GLUT, DA, NE and 5-HT) in the brain, while CREB and BDNF gene expression was determined using qPCR. Results showed that BUP reached a Cmax of 1.21 ± 0.0523 ng/mL after 2 h, with all neurotransmitters showing an increase in their concentration over time, with GABA, GLUT and NE reaching their maximum concentration after 8 h. DA and 5-HT reached their maximum concentrations at 1 h and 24 h, respectively post drug administration. Treatment with BUP resulted in significant upregulation in BDNF expression throughout the treatment period while CREB showed patterns of significant upregulation at 2 and 8 h, and downregulation at 1 and 6 h. This study contributes to the understanding of the pharmacodynamic effects of BUP in opioid addiction by proving that the drug significantly influences NT pathways that are implicated in opioid addiction.
Buprenorphine is an opioid drug used in the management of pain and the treatment opioid addiction. Like other opioids, it is believed that it achieves these effects by altering functional neurotransmitter pathways and the expression of important transcription factors; cyclic AMP response element-binding protein (CREB) and brain-derived neurotrophic factor (BDNF) in the brain. However, there is a lack of scientific evidence to support these theories. This study investigated the pharmacodynamic effects of BUP administration by assessing neurotransmitter and molecular changes in the healthy rodent brain. Sprague-Dawley rats (150–200 g) were intranasally administered buprenorphine (0.3 mg/mL) and sacrificed at different time points: 0.25, 0.5, 1, 2, 4, 6, 8 and 24 h post drug administration. LC-MS was used to quantify BUP and neurotransmitters (GABA, GLUT, DA, NE and 5-HT) in the brain, while CREB and BDNF gene expression was determined using qPCR. Results showed that BUP reached a Cmax of 1.21 ± 0.0523 ng/mL after 2 h, with all neurotransmitters showing an increase in their concentration over time, with GABA, GLUT and NE reaching their maximum concentration after 8 h. DA and 5-HT reached their maximum concentrations at 1 h and 24 h, respectively post drug administration. Treatment with BUP resulted in significant upregulation in BDNF expression throughout the treatment period while CREB showed patterns of significant upregulation at 2 and 8 h, and downregulation at 1 and 6 h. This study contributes to the understanding of the pharmacodynamic effects of BUP in opioid addiction by proving that the drug significantly influences NT pathways that are implicated in opioid addiction. •The pharmacokinetics of BUP and its effects on neurotransmitters and the expression of CREB and BDNF were investigated.•BUP reached a Cmax 2 h post BUP administration with GABA, GLUT and NE reaching their maximum concentrations after 8 h.•DA and 5-HT peaked at 1 h and 8 h post-dose, respectively.•BUP significantly increased the expression of BDNF throughout the treatment period, while CREB showed variable expression.
Buprenorphine is an opioid drug used in the management of pain and the treatment opioid addiction. Like other opioids, it is believed that it achieves these effects by altering functional neurotransmitter pathways and the expression of important transcription factors; cyclic AMP response element-binding protein (CREB) and brain-derived neurotrophic factor (BDNF) in the brain. However, there is a lack of scientific evidence to support these theories. This study investigated the pharmacodynamic effects of BUP administration by assessing neurotransmitter and molecular changes in the healthy rodent brain. Sprague-Dawley rats (150–200 g) were intranasally administered buprenorphine (0.3 mg/mL) and sacrificed at different time points: 0.25, 0.5, 1, 2, 4, 6, 8 and 24 h post drug administration. LC-MS was used to quantify BUP and neurotransmitters (GABA, GLUT, DA, NE and 5-HT) in the brain, while CREB and BDNF gene expression was determined using qPCR. Results showed that BUP reached a Cmax of 1.21 ± 0.0523 ng/mL after 2 h, with all neurotransmitters showing an increase in their concentration over time, with GABA, GLUT and NE reaching their maximum concentration after 8 h. DA and 5-HT reached their maximum concentrations at 1 h and 24 h, respectively post drug administration. Treatment with BUP resulted in significant upregulation in BDNF expression throughout the treatment period while CREB showed patterns of significant upregulation at 2 and 8 h, and downregulation at 1 and 6 h. This study contributes to the understanding of the pharmacodynamic effects of BUP in opioid addiction by proving that the drug significantly influences NT pathways that are implicated in opioid addiction.
Buprenorphine is an opioid drug used in the management of pain and the treatment opioid addiction. Like other opioids, it is believed that it achieves these effects by altering functional neurotransmitter pathways and the expression of important transcription factors; cyclic AMP response element-binding protein (CREB) and brain-derived neurotrophic factor (BDNF) in the brain. However, there is a lack of scientific evidence to support these theories. This study investigated the pharmacodynamic effects of BUP administration by assessing neurotransmitter and molecular changes in the healthy rodent brain. Sprague-Dawley rats (150-200 g) were intranasally administered buprenorphine (0.3 mg/mL) and sacrificed at different time points: 0.25, 0.5, 1, 2, 4, 6, 8 and 24 h post drug administration. LC-MS was used to quantify BUP and neurotransmitters (GABA, GLUT, DA, NE and 5-HT) in the brain, while CREB and BDNF gene expression was determined using qPCR. Results showed that BUP reached a C of 1.21 ± 0.0523 ng/mL after 2 h, with all neurotransmitters showing an increase in their concentration over time, with GABA, GLUT and NE reaching their maximum concentration after 8 h. DA and 5-HT reached their maximum concentrations at 1 h and 24 h, respectively post drug administration. Treatment with BUP resulted in significant upregulation in BDNF expression throughout the treatment period while CREB showed patterns of significant upregulation at 2 and 8 h, and downregulation at 1 and 6 h. This study contributes to the understanding of the pharmacodynamic effects of BUP in opioid addiction by proving that the drug significantly influences NT pathways that are implicated in opioid addiction.
ArticleNumber 111515
Author Kruger, Hendrik G.
Naicker, Tricia
Khoza, Leon J.
Madurai, Lorna
Ghazi, Terisha
Molopa, Molopa J.
Dhani, Shanel
Govender, Thavendran
Baijnath, Sooraj
Singh, Sanil D.
Chuturgoon, Anil
Madurai, Nithia P.
Xhakaza, Sanelisiwe P.
Haripershad, Advaitaa M.
Mutsimhu, Cosmas
Gopal, Nirmala D.
Author_xml – sequence: 1
  givenname: Sanelisiwe P.
  surname: Xhakaza
  fullname: Xhakaza, Sanelisiwe P.
  organization: Catalysis and Peptide Research Unit, Department of Pharmaceutical Sciences, College of Health Science, University of KwaZulu-Natal, Durban, 4001, South Africa
– sequence: 2
  givenname: Leon J.
  surname: Khoza
  fullname: Khoza, Leon J.
  organization: Catalysis and Peptide Research Unit, Department of Pharmaceutical Sciences, College of Health Science, University of KwaZulu-Natal, Durban, 4001, South Africa
– sequence: 3
  givenname: Advaitaa M.
  surname: Haripershad
  fullname: Haripershad, Advaitaa M.
  organization: Catalysis and Peptide Research Unit, Department of Pharmaceutical Sciences, College of Health Science, University of KwaZulu-Natal, Durban, 4001, South Africa
– sequence: 4
  givenname: Terisha
  surname: Ghazi
  fullname: Ghazi, Terisha
  organization: Discipline of Medical Biochemistry, School of Laboratory Medicine and Medical Science, University of KwaZulu-Natal, Durban, 4001, South Africa
– sequence: 5
  givenname: Shanel
  surname: Dhani
  fullname: Dhani, Shanel
  organization: Discipline of Medical Biochemistry, School of Laboratory Medicine and Medical Science, University of KwaZulu-Natal, Durban, 4001, South Africa
– sequence: 6
  givenname: Cosmas
  surname: Mutsimhu
  fullname: Mutsimhu, Cosmas
  organization: Viro Care (SA) Pty Ltd, 12 The Avenue East, Prospecton, Durban 4113, South Africa
– sequence: 7
  givenname: Molopa J.
  surname: Molopa
  fullname: Molopa, Molopa J.
  organization: Viro Care (SA) Pty Ltd, 12 The Avenue East, Prospecton, Durban 4113, South Africa
– sequence: 8
  givenname: Nithia P.
  surname: Madurai
  fullname: Madurai, Nithia P.
  organization: Viro Care (SA) Pty Ltd, 12 The Avenue East, Prospecton, Durban 4113, South Africa
– sequence: 9
  givenname: Lorna
  surname: Madurai
  fullname: Madurai, Lorna
  organization: Viro Care (SA) Pty Ltd, 12 The Avenue East, Prospecton, Durban 4113, South Africa
– sequence: 10
  givenname: Sanil D.
  surname: Singh
  fullname: Singh, Sanil D.
  organization: Catalysis and Peptide Research Unit, Department of Pharmaceutical Sciences, College of Health Science, University of KwaZulu-Natal, Durban, 4001, South Africa
– sequence: 11
  givenname: Nirmala D.
  surname: Gopal
  fullname: Gopal, Nirmala D.
  organization: Department of Criminology, University of KwaZulu-Natal, Durban 4001, South Africa
– sequence: 12
  givenname: Hendrik G.
  surname: Kruger
  fullname: Kruger, Hendrik G.
  organization: Catalysis and Peptide Research Unit, Department of Pharmaceutical Sciences, College of Health Science, University of KwaZulu-Natal, Durban, 4001, South Africa
– sequence: 13
  givenname: Thavendran
  surname: Govender
  fullname: Govender, Thavendran
  organization: Department of Chemistry, University of Zululand, Private Bag X1001, KwaDlangezwa 3886, South Africa
– sequence: 14
  givenname: Anil
  surname: Chuturgoon
  fullname: Chuturgoon, Anil
  organization: Discipline of Medical Biochemistry, School of Laboratory Medicine and Medical Science, University of KwaZulu-Natal, Durban, 4001, South Africa
– sequence: 15
  givenname: Tricia
  surname: Naicker
  fullname: Naicker, Tricia
  organization: Catalysis and Peptide Research Unit, Department of Pharmaceutical Sciences, College of Health Science, University of KwaZulu-Natal, Durban, 4001, South Africa
– sequence: 16
  givenname: Sooraj
  surname: Baijnath
  fullname: Baijnath, Sooraj
  email: baijnaths@ukzn.ac.za
  organization: Catalysis and Peptide Research Unit, Department of Pharmaceutical Sciences, College of Health Science, University of KwaZulu-Natal, Durban, 4001, South Africa
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33752062$$D View this record in MEDLINE/PubMed
BookMark eNp9kUtr3TAQhUVJaW7S_oNSvOzGt3pa9qYQQh-BQDftWozkcaKLLbmSnabQH1_d6zTLgkAwc-acGb4LchZiQELeMrpnlDUfDnvr43wPe0452zPGFFMvyI51itYNpfqM7KhWohaC83NykfOBUqoa0b4i50JoxWnDd-TP1bhggsXHkCsfqoBrikuCkCe_lE414gOOuYLQV6eyS34-qqsB3BJThY9zwpxPlTiO8ZcPd8XoqIUMY2XX0g8xzfc-YAX95IPPy5b4mrwcYMz45um_JD8-f_p-_bW-_fbl5vrqtnZSy6VWIKA8DWVlK5gUrqUW7VAuboWVzDYguaRN1zbcisaBEgx6NrAOOmTaiUtys_n2EQ5mTn6C9NtE8OZUiOnOQFq8G9FYyV03QItCM9kMqsXegaUwOK4Z1UPxer95zSn-XDEvZvLZ4ThCwLhmwxWVQlLe6SKVm9SlmHPC4TmaUXNkaA5mY2iODM3GsIy9e0pY7YT989A_aEXwcRMUMPjgMZnsPAaHvU_olnKU_3_CX9fUtKE
CitedBy_id crossref_primary_10_1007_s11356_024_33447_y
crossref_primary_10_1016_j_etap_2022_103979
crossref_primary_10_1016_j_heliyon_2022_e11432
Cites_doi 10.1097/00001756-200108280-00017
10.7554/eLife.26801
10.1016/j.neubiorev.2009.02.005
10.1002/syn.890190309
10.1177/0269881111411332
10.1086/701377
10.2147/NDT.S70585
10.3389/fphar.2016.00514
10.2174/156720211796558032
10.1016/j.neuint.2019.104521
10.1016/j.neulet.2014.04.048
10.1111/j.2042-7158.2011.01384.x
10.1523/JNEUROSCI.4701-05.2006
10.1038/nn.3932
10.1080/13556210412331308994
10.1007/s10337-011-2095-2
10.1016/j.chroma.2015.03.056
10.1016/j.tins.2005.06.005
10.1151/spp021113
10.1177/0963689718811060
10.1016/j.jneumeth.2011.03.023
10.2217/nnm-2017-0365
10.1016/j.bbr.2014.07.038
10.1016/j.biopsych.2006.04.043
10.1016/j.pharep.2014.11.002
10.1016/j.neuropharm.2017.04.033
10.1038/sj.npp.1300416
10.1016/j.jmgm.2019.01.007
10.4161/cib.13761
10.1371/journal.pone.0072578
10.1039/c0an00256a
10.1016/j.neuropharm.2015.09.031
10.1515/revneuro-2016-0078
10.1016/S0928-0987(02)00009-X
10.1177/0269881107078491
10.1016/j.molbrainres.2005.07.008
10.1126/science.1222265
10.1177/00912709922008236
10.1111/j.1360-0443.2011.03424.x
10.1016/j.neuropharm.2007.01.005
10.1111/j.1471-4159.2010.07080.x
10.1007/s11064-019-02851-z
10.3389/fncel.2018.00273
10.1111/j.2042-7158.2012.01555.x
10.1007/s40265-018-0953-z
10.1186/s13063-018-3055-z
10.1101/cshperspect.a012088
10.1006/meth.2001.1262
10.55782/ane-2000-1376
10.1016/j.comppsych.2015.11.010
ContentType Journal Article
Copyright 2021
Copyright © 2021. Published by Elsevier Masson SAS.
Copyright_xml – notice: 2021
– notice: Copyright © 2021. Published by Elsevier Masson SAS.
DBID 6I.
AAFTH
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOA
DOI 10.1016/j.biopha.2021.111515
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1950-6007
EndPage 111515
ExternalDocumentID oai_doaj_org_article_b42c9fa8e37146f58edcab0afc27107f
10_1016_j_biopha_2021_111515
33752062
S0753332221003000
Genre Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
0SF
1B1
1P~
1RT
1~.
1~5
23N
4.4
457
4CK
4G.
53G
5GY
5RE
5VS
6I.
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAFTH
AAFWJ
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATCM
AAXUO
ABBQC
ABFNM
ABLVK
ABMAC
ABMZM
ABXDB
ABYKQ
ABZDS
ACDAQ
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
AEBSH
AEKER
AENEX
AEVXI
AFCTW
AFKWA
AFPKN
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AI.
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
AJUYK
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
GROUPED_DOAJ
HMT
HVGLF
HZ~
IHE
J1W
KOM
LCYCR
M34
M41
MO0
N9A
NCXOZ
O-L
O9-
OAUVE
OD~
OGGZJ
OK1
OO0
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SDF
SDG
SDP
SEM
SES
SEW
SPT
SSH
SSP
SSZ
T5K
VH1
WUQ
Z5R
~02
~G-
AAXKI
ADVLN
AFJKZ
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c474t-5a3aa3a7a206b3143c80bebf15183b41b6a424069862b36ca531ad1f19a9e17c3
IEDL.DBID DOA
ISSN 0753-3322
IngestDate Tue Oct 22 15:09:02 EDT 2024
Fri Oct 25 05:55:15 EDT 2024
Thu Sep 26 20:33:39 EDT 2024
Thu Oct 24 09:58:03 EDT 2024
Fri Feb 23 02:34:54 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords Opioid addiction
Neurotransmitters
Buprenorphine
Brain-derived neurotrophic factor (BDNF)
Cyclic AMP response element-binding protein (CREB)
Language English
License This is an open access article under the CC BY-NC-ND license.
Copyright © 2021. Published by Elsevier Masson SAS.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c474t-5a3aa3a7a206b3143c80bebf15183b41b6a424069862b36ca531ad1f19a9e17c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doaj.org/article/b42c9fa8e37146f58edcab0afc27107f
PMID 33752062
PQID 2504340297
PQPubID 23479
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_b42c9fa8e37146f58edcab0afc27107f
proquest_miscellaneous_2504340297
crossref_primary_10_1016_j_biopha_2021_111515
pubmed_primary_33752062
elsevier_sciencedirect_doi_10_1016_j_biopha_2021_111515
PublicationCentury 2000
PublicationDate June 2021
2021-Jun
2021-06-00
20210601
2021-06-01
PublicationDateYYYYMMDD 2021-06-01
PublicationDate_xml – month: 06
  year: 2021
  text: June 2021
PublicationDecade 2020
PublicationPlace France
PublicationPlace_xml – name: France
PublicationTitle Biomedicine & pharmacotherapy
PublicationTitleAlternate Biomed Pharmacother
PublicationYear 2021
Publisher Elsevier Masson SAS
Elsevier
Publisher_xml – name: Elsevier Masson SAS
– name: Elsevier
References Sghendo, Mifsud (bib13) 2012; 64
Chen, Chiang, Yuan, Kuo, Lai, Hung (bib3) 2015; 11
Davis, Pasternak, Behm (bib10) 2018; 78
Tufi, Lamoree, de Boer, Leonards (bib11) 2015; 1395
Angelucci, Ricci, Pomponi, Conte, Mathé, Attilio Tonali, Bria (bib44) 2007; 21
Persico, Schindler, Zaczek, Brannock, Uhl (bib29) 1995; 19
Zhang, Jiang, Zhang, Du, Wang, Zhao (bib43) 2016; 65
Heberlein, Dürsteler-MacFarland, Lenz, Frieling, Grösch, Bönsch, Kornhuber, Wiesbeck, Bleich, Hillemacher (bib45) 2011; 25
Kosten, George (bib28) 2002; 1
Tonel, González-Durruthy, Zanella, Fagan (bib26) 2019; 88
Bilecki, Przewlocki (bib35) 2000; 60
Grogan, Tsivos, Smith, Knight, Bogacz, Whone, Coulthard (bib21) 2017; 6
Cheng, Hong, Yu, Chen, Wu, Tsai (bib37) 2005; 140
Porcher, Medina, Gaiarsa (bib39) 2018; 12
Varma, Sapra, Iranmanesh (bib8) 2018; 36
Renner, Svitak, Gallus, Ericson, Frey, Hanson (bib55) 2012; 64
Marin, McMillin (bib1) 2016
Wei, Wang, Yin, Liu, Zou, Ye (bib14) 2010; 135
Livak, Schmittgen (bib49) 2001; 25
Zhang, Wu, Zhang, Liu, Jiang, Pang, Tao, Dong, Stackman (bib17) 2016; 101
Peters, De (bib27) 2012; 2
Nath, Upton, Everhart, Cheung, Shwonek, Jones, Mendelson (bib2) 1999; 39
González, Fernández, Vidal, Frenich, Pérez (bib12) 2011; 198
Rezai, Mahmoodi, Kaeidi, Karimabad, Khoshdel, Hajizadeh (bib56) 2018; 8
Wang (bib4) 2019; 28
Valverde, Mantamadiotis, Torrecilla, Ugedo, Pineda, Bleckmann, Gass, Kretz, Mitchell, Schütz (bib31) 2004; 29
Sakamoto, Karelina, Obrietan (bib33) 2011; 116
Middleton, Nuzzo, Lofwall, Moody, Walsh (bib52) 2011; 106
Chiang, Pao, Hsiong, Huang, Lin, Hu (bib53) 2011; 74
Gopal, Tzeng, Cowan (bib51) 2002; 15
Rouhani, Khodarahmi, Naseh, BDNF (bib46) 2019; 44
Han, Bolanos, Green, Olson, Neve, Liu, Aghajanian, Nestler (bib34) 2006; 26
Alenina, Klempin (bib16) 2015; 277
Shobo, Pamreddy, Kruger, Makatini, Naicker, Govender, Baijnath (bib48) 2018; 13
Guo, Wang, Xiang, Zhao (bib25) 2009; 33
Campos-Jurado, Igual-López, Padilla, Zornoza, Granero, Polache, Agustín-Pavón, Hipólito (bib24) 2019; 131
Pang, Wu, Tao, Mao, Liu, Zhang, Li, Stackman, Dong, Zhang (bib15) 2016; 7
Suo, Ishiura (bib36) 2013; 8
Palma-Álvarez, Ros-Cucurull, Amaro-Hosey, Rodriguez-Cintas, Grau-López, Corominas-Roso, Sánchez-Mora, Roncero (bib38) 2017; 28
Koo, Mazei-Robison, LaPlant, Egervari, Braunscheidel, Adank, Ferguson, Feng, Sun, Scobie (bib47) 2015; 18
Greenwald, Johanson, Bueller, Chang, Moody, Kilbourn, Koeppe, Zubieta (bib7) 2007; 61
Kendall, Hansen, Dorsey, Kang, Lunghofer, Gustafson (bib50) 2014; 53
Pascual, Climent, Guerri (bib42) 2001; 12
Marquez, Baliram, Kieffer, Lutfy (bib54) 2007; 52
Kahan, Srivastava, Ordean, Cirone (bib9) 2011; 57
Khanna, Pillarisetti (bib5) 2015; 8
Ahmadi, Jahromi, Ghahremani, London (bib6) 2018; 19
Carlezon, Duman, Nestler (bib30) 2005; 28
Koo, Mazei-Robison, Chaudhury, Juarez, LaPlant, Ferguson, Feng, Sun, Scobie, Damez-Werno (bib23) 2012; 338
Miller (bib22) 2019; 236
Martin, Finsterwald (bib41) 2011; 4
Zaniewska, McCreary, Wydra, Faron-Górecka, Filip (bib18) 2015; 67
Covey, Mateo, Sulzer, Cheer, Lovinger (bib19) 2017; 124
Ammon‐Treiber, Höllt (bib32) 2005; 10
Zhang, Zhang, Su, Tao, Xie, Han, Lu, Wei, Sun, Wang (bib40) 2014; 571
Khosrow Tayebati, Lokhandwala, Amenta (bib20) 2011; 8
Miller (10.1016/j.biopha.2021.111515_bib22) 2019; 236
Marquez (10.1016/j.biopha.2021.111515_bib54) 2007; 52
Tonel (10.1016/j.biopha.2021.111515_bib26) 2019; 88
Ahmadi (10.1016/j.biopha.2021.111515_bib6) 2018; 19
Wei (10.1016/j.biopha.2021.111515_bib14) 2010; 135
Sghendo (10.1016/j.biopha.2021.111515_bib13) 2012; 64
Cheng (10.1016/j.biopha.2021.111515_bib37) 2005; 140
Chiang (10.1016/j.biopha.2021.111515_bib53) 2011; 74
Heberlein (10.1016/j.biopha.2021.111515_bib45) 2011; 25
Ammon‐Treiber (10.1016/j.biopha.2021.111515_bib32) 2005; 10
Valverde (10.1016/j.biopha.2021.111515_bib31) 2004; 29
Tufi (10.1016/j.biopha.2021.111515_bib11) 2015; 1395
Gopal (10.1016/j.biopha.2021.111515_bib51) 2002; 15
Kahan (10.1016/j.biopha.2021.111515_bib9) 2011; 57
Persico (10.1016/j.biopha.2021.111515_bib29) 1995; 19
Han (10.1016/j.biopha.2021.111515_bib34) 2006; 26
Martin (10.1016/j.biopha.2021.111515_bib41) 2011; 4
Koo (10.1016/j.biopha.2021.111515_bib23) 2012; 338
Livak (10.1016/j.biopha.2021.111515_bib49) 2001; 25
Suo (10.1016/j.biopha.2021.111515_bib36) 2013; 8
Khanna (10.1016/j.biopha.2021.111515_bib5) 2015; 8
Zhang (10.1016/j.biopha.2021.111515_bib17) 2016; 101
Renner (10.1016/j.biopha.2021.111515_bib55) 2012; 64
Middleton (10.1016/j.biopha.2021.111515_bib52) 2011; 106
Nath (10.1016/j.biopha.2021.111515_bib2) 1999; 39
Zaniewska (10.1016/j.biopha.2021.111515_bib18) 2015; 67
Zhang (10.1016/j.biopha.2021.111515_bib43) 2016; 65
Marin (10.1016/j.biopha.2021.111515_bib1) 2016
Chen (10.1016/j.biopha.2021.111515_bib3) 2015; 11
Davis (10.1016/j.biopha.2021.111515_bib10) 2018; 78
Wang (10.1016/j.biopha.2021.111515_bib4) 2019; 28
Bilecki (10.1016/j.biopha.2021.111515_bib35) 2000; 60
Grogan (10.1016/j.biopha.2021.111515_bib21) 2017; 6
Kosten (10.1016/j.biopha.2021.111515_bib28) 2002; 1
Kendall (10.1016/j.biopha.2021.111515_bib50) 2014; 53
Alenina (10.1016/j.biopha.2021.111515_bib16) 2015; 277
Porcher (10.1016/j.biopha.2021.111515_bib39) 2018; 12
Campos-Jurado (10.1016/j.biopha.2021.111515_bib24) 2019; 131
Rezai (10.1016/j.biopha.2021.111515_bib56) 2018; 8
Rouhani (10.1016/j.biopha.2021.111515_bib46) 2019; 44
Carlezon (10.1016/j.biopha.2021.111515_bib30) 2005; 28
Shobo (10.1016/j.biopha.2021.111515_bib48) 2018; 13
Greenwald (10.1016/j.biopha.2021.111515_bib7) 2007; 61
Pascual (10.1016/j.biopha.2021.111515_bib42) 2001; 12
Palma-Álvarez (10.1016/j.biopha.2021.111515_bib38) 2017; 28
Varma (10.1016/j.biopha.2021.111515_bib8) 2018; 36
González (10.1016/j.biopha.2021.111515_bib12) 2011; 198
Angelucci (10.1016/j.biopha.2021.111515_bib44) 2007; 21
Peters (10.1016/j.biopha.2021.111515_bib27) 2012; 2
Sakamoto (10.1016/j.biopha.2021.111515_bib33) 2011; 116
Covey (10.1016/j.biopha.2021.111515_bib19) 2017; 124
Guo (10.1016/j.biopha.2021.111515_bib25) 2009; 33
Pang (10.1016/j.biopha.2021.111515_bib15) 2016; 7
Khosrow Tayebati (10.1016/j.biopha.2021.111515_bib20) 2011; 8
Koo (10.1016/j.biopha.2021.111515_bib47) 2015; 18
Zhang (10.1016/j.biopha.2021.111515_bib40) 2014; 571
References_xml – volume: 25
  start-page: 1480
  year: 2011
  end-page: 1484
  ident: bib45
  article-title: Serum levels of BDNF are associated with craving in opiate-dependent patients
  publication-title: J. Psychopharmacol.
  contributor:
    fullname: Hillemacher
– volume: 140
  start-page: 86
  year: 2005
  end-page: 90
  ident: bib37
  article-title: Brain-derived neurotrophic factor (Val66Met) genetic polymorphism is associated with substance abuse in males
  publication-title: Mol. Brain Res.
  contributor:
    fullname: Tsai
– volume: 116
  start-page: 1
  year: 2011
  end-page: 9
  ident: bib33
  article-title: CREB: a multifaceted regulator of neuronal plasticity and protection
  publication-title: J. Neurochem.
  contributor:
    fullname: Obrietan
– volume: 65
  start-page: 150
  year: 2016
  end-page: 155
  ident: bib43
  article-title: Brain-derived neurotrophic factor serum levels in heroin-dependent patients after 26 weeks of withdrawal
  publication-title: Compr. Psychiatry
  contributor:
    fullname: Zhao
– volume: 60
  start-page: 557
  year: 2000
  end-page: 567
  ident: bib35
  article-title: Effect of opioids on Ca2+/cAMP responsive element binding protein
  publication-title: Acta Neurobiol. Exp.
  contributor:
    fullname: Przewlocki
– volume: 18
  start-page: 415
  year: 2015
  end-page: 422
  ident: bib47
  article-title: Epigenetic basis of opiate suppression of Bdnf gene expression in the ventral tegmental area
  publication-title: Nat. Neurosci.
  contributor:
    fullname: Scobie
– volume: 78
  start-page: 1211
  year: 2018
  end-page: 1228
  ident: bib10
  article-title: Treating chronic pain: an overview of clinical studies centered on the buprenorphine option
  publication-title: Drugs
  contributor:
    fullname: Behm
– volume: 198
  start-page: 187
  year: 2011
  end-page: 194
  ident: bib12
  article-title: Development and validation of an ultra-high performance liquid chromatography–tandem mass-spectrometry (UHPLC–MS/MS) method for the simultaneous determination of neurotransmitters in rat brain samples
  publication-title: J. Neurosci. Methods
  contributor:
    fullname: Pérez
– volume: 106
  start-page: 1460
  year: 2011
  end-page: 1473
  ident: bib52
  article-title: The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers
  publication-title: Addiction
  contributor:
    fullname: Walsh
– volume: 25
  start-page: 402
  year: 2001
  end-page: 408
  ident: bib49
  article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method
  publication-title: Methods
  contributor:
    fullname: Schmittgen
– volume: 236
  start-page: 144
  year: 2019
  end-page: 156
  ident: bib22
  article-title: GABA as a neurotransmitter in Gastropod Molluscs
  publication-title: Biol. Bull.
  contributor:
    fullname: Miller
– volume: 64
  start-page: 1709
  year: 2012
  end-page: 1714
  ident: bib55
  article-title: Intranasal delivery of insulin via the olfactory nerve pathway
  publication-title: J. Pharm. Pharmacol.
  contributor:
    fullname: Hanson
– volume: 19
  start-page: 675
  year: 2018
  ident: bib6
  article-title: Single high-dose buprenorphine for opioid craving during withdrawal
  publication-title: Trials
  contributor:
    fullname: London
– volume: 19
  start-page: 212
  year: 1995
  end-page: 227
  ident: bib29
  article-title: Brain transcription factor gene expression, neurotransmitter levels, and novelty response behaviors: alterations during rat amphetamine withdrawal and following chronic injection stress
  publication-title: Synapse
  contributor:
    fullname: Uhl
– volume: 44
  start-page: 2139
  year: 2019
  end-page: 2146
  ident: bib46
  article-title: and Arc mRNA expression in the hippocampus of rats after administration of morphine
  publication-title: Neurochem. Res.
  contributor:
    fullname: BDNF
– volume: 67
  start-page: 451
  year: 2015
  end-page: 459
  ident: bib18
  article-title: Context-controlled nicotine-induced changes in the labeling of serotonin (5-HT) 2A and 5-HT2C receptors in the rat brain
  publication-title: Pharmacol. Rep.
  contributor:
    fullname: Filip
– volume: 39
  start-page: 619
  year: 1999
  end-page: 623
  ident: bib2
  article-title: Buprenorphine pharmacokinetics: relative bioavailability of sublingual tablet and liquid formulations
  publication-title: The Journal of Clinical Pharmacology
  contributor:
    fullname: Mendelson
– volume: 10
  start-page: 81
  year: 2005
  end-page: 89
  ident: bib32
  article-title: Morphine‐induced changes of gene expression in the brain
  publication-title: Addict. Biol.
  contributor:
    fullname: Höllt
– volume: 8
  year: 2013
  ident: bib36
  article-title: Dopamine modulates acetylcholine release via octopamine and CREB signaling in Caenorhabditis elegans
  publication-title: PLoS One
  contributor:
    fullname: Ishiura
– volume: 8
  start-page: 246
  year: 2011
  end-page: 257
  ident: bib20
  article-title: Dopamine and vascular dynamics control: present status and future perspectives
  publication-title: Curr. Neurovasc. Res.
  contributor:
    fullname: Amenta
– volume: 11
  start-page: 609
  year: 2015
  ident: bib3
  article-title: Buprenorphine, methadone, and morphine treatment during pregnancy: behavioral effects on the offspring in rats
  publication-title: NDT
  contributor:
    fullname: Hung
– volume: 135
  start-page: 2286
  year: 2010
  end-page: 2290
  ident: bib14
  article-title: Selective detection of neurotransmitter serotonin by a gold nanoparticle-modified glassy carbon electrode
  publication-title: Analyst
  contributor:
    fullname: Ye
– volume: 338
  start-page: 124
  year: 2012
  end-page: 128
  ident: bib23
  article-title: BDNF is a negative modulator of morphine action
  publication-title: Science
  contributor:
    fullname: Damez-Werno
– volume: 53
  start-page: 478
  year: 2014
  end-page: 484
  ident: bib50
  article-title: Pharmacokinetics of sustained-release analgesics in mice
  publication-title: J. Am. Assoc. Lab. Animal Sci.
  contributor:
    fullname: Gustafson
– volume: 61
  start-page: 101
  year: 2007
  end-page: 110
  ident: bib7
  article-title: Buprenorphine duration of action: mu-opioid receptor availability and pharmacokinetic and behavioral indices
  publication-title: Biol. Psychiatry
  contributor:
    fullname: Zubieta
– start-page: 59
  year: 2016
  end-page: 68
  ident: bib1
  article-title: Quantitation of total buprenorphine and norbuprenorphine in meconium by LC-MS/MS
  publication-title: Clinical Applications of Mass Spectrometry in Drug Analysis
  contributor:
    fullname: McMillin
– volume: 12
  start-page: 273
  year: 2018
  ident: bib39
  article-title: Mechanism of BDNF modulation in GABAergic synaptic transmission in healthy and disease brains
  publication-title: Front. Cell. Neurosci.
  contributor:
    fullname: Gaiarsa
– volume: 28
  start-page: 233
  year: 2019
  end-page: 238
  ident: bib4
  article-title: Historical review: opiate addiction and opioid receptors
  publication-title: Cell Transplant
  contributor:
    fullname: Wang
– volume: 8
  start-page: 859
  year: 2015
  ident: bib5
  article-title: Buprenorphine – an attractive opioid with underutilized potential in treatment of chronic pain
  publication-title: JPR
  contributor:
    fullname: Pillarisetti
– volume: 6
  year: 2017
  ident: bib21
  article-title: Effects of dopamine on reinforcement learning and consolidation in Parkinson’s disease
  publication-title: Elife
  contributor:
    fullname: Coulthard
– volume: 1395
  start-page: 79
  year: 2015
  end-page: 87
  ident: bib11
  article-title: Simultaneous analysis of multiple neurotransmitters by hydrophilic interaction liquid chromatography coupled to tandem mass spectrometry
  publication-title: J. Chromatogr. A
  contributor:
    fullname: Leonards
– volume: 26
  start-page: 4624
  year: 2006
  end-page: 4629
  ident: bib34
  article-title: Role of cAMP response element-binding protein in the rat locus ceruleus: regulation of neuronal activity and opiate withdrawal behaviors
  publication-title: J. Neurosci.
  contributor:
    fullname: Nestler
– volume: 1
  start-page: 13
  year: 2002
  end-page: 20
  ident: bib28
  article-title: The neurobiology of opioid dependence: implications for treatment
  publication-title: Sci. Prac. Perspec.
  contributor:
    fullname: George
– volume: 12
  start-page: 2673
  year: 2001
  end-page: 2677
  ident: bib42
  article-title: BDNF induces glutamate release in cerebrocortical nerve terminals and in cortical astrocytes
  publication-title: Neuroreport
  contributor:
    fullname: Guerri
– volume: 13
  start-page: 997
  year: 2018
  end-page: 1008
  ident: bib48
  article-title: Enhanced brain penetration of pretomanid by intranasal administration of an oil-in-water nanoemulsion
  publication-title: Nanomedicine
  contributor:
    fullname: Baijnath
– volume: 74
  start-page: 575
  year: 2011
  end-page: 583
  ident: bib53
  article-title: Simultaneous determination of buprenorphine, norbuprenorphine and naloxone in human plasma by LC-MS-MS
  publication-title: Chromatographia
  contributor:
    fullname: Hu
– volume: 57
  start-page: 281
  year: 2011
  end-page: 289
  ident: bib9
  article-title: Buprenorphine: new treatment of opioid addiction in primary care
  publication-title: Can. Fam. Phys.
  contributor:
    fullname: Cirone
– volume: 7
  start-page: 514
  year: 2016
  ident: bib15
  article-title: Blockade of serotonin 5-HT2A receptors suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in morphine-treated mice
  publication-title: Front. Pharmacol.
  contributor:
    fullname: Zhang
– volume: 101
  start-page: 246
  year: 2016
  end-page: 254
  ident: bib17
  article-title: Activation of serotonin 5-HT2C receptor suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in morphine-dependent mice
  publication-title: Neuropharmacology
  contributor:
    fullname: Stackman
– volume: 33
  start-page: 864
  year: 2009
  end-page: 873
  ident: bib25
  article-title: The role of glutamate and its receptors in mesocorticolimbic dopaminergic regions in opioid addiction
  publication-title: Neurosci. Biobehav. Rev.
  contributor:
    fullname: Zhao
– volume: 4
  start-page: 14
  year: 2011
  end-page: 16
  ident: bib41
  article-title: Cooperation between BDNF and glutamate in the regulation of synaptic transmission and neuronal development
  publication-title: Commun. Integr. Biol.
  contributor:
    fullname: Finsterwald
– volume: 131
  year: 2019
  ident: bib24
  article-title: Activation of MORs in the VTA induces changes on cFos expression in different projecting regions: effect of inflammatory pain
  publication-title: Neurochem. Int.
  contributor:
    fullname: Hipólito
– volume: 571
  start-page: 61
  year: 2014
  end-page: 65
  ident: bib40
  article-title: Increased serum brain-derived neurotrophic factor levels during opiate withdrawal
  publication-title: Neurosci. Lett.
  contributor:
    fullname: Wang
– volume: 29
  start-page: 1122
  year: 2004
  end-page: 1133
  ident: bib31
  article-title: Modulation of anxiety-like behavior and morphine dependence in CREB-deficient mice
  publication-title: Neuropsychopharmacology
  contributor:
    fullname: Schütz
– volume: 8
  start-page: 387
  year: 2018
  end-page: 393
  ident: bib56
  article-title: Effect of crocin carotenoid on BDNF and CREB gene expression in brain ventral tegmental area of morphine treated rats, Asian Pacific Journal of Tropical Biomedicine
  contributor:
    fullname: Hajizadeh
– volume: 36
  year: 2018
  ident: bib8
  article-title: Impact of opioid therapy on gonadal hormones: focus on buprenorphine
  publication-title: Horm. Mol. Biol. Clin. Investig.
  contributor:
    fullname: Iranmanesh
– volume: 124
  start-page: 52
  year: 2017
  end-page: 61
  ident: bib19
  article-title: Endocannabinoid modulation of dopamine neurotransmission
  publication-title: Neuropharmacology
  contributor:
    fullname: Lovinger
– volume: 64
  start-page: 317
  year: 2012
  end-page: 325
  ident: bib13
  article-title: Understanding the molecular pharmacology of the serotonergic system: using fluoxetine as a model
  publication-title: J. Pharm. Pharmacol.
  contributor:
    fullname: Mifsud
– volume: 21
  start-page: 820
  year: 2007
  end-page: 825
  ident: bib44
  article-title: Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factor
  publication-title: J. Psychopharmacol.
  contributor:
    fullname: Bria
– volume: 28
  start-page: 499
  year: 2017
  end-page: 508
  ident: bib38
  article-title: Peripheral levels of BDNF and opiate-use disorder: literature review and update
  publication-title: Rev. Neurosci.
  contributor:
    fullname: Roncero
– volume: 28
  start-page: 436
  year: 2005
  end-page: 445
  ident: bib30
  article-title: The many faces of CREB
  publication-title: Trends Neurosci.
  contributor:
    fullname: Nestler
– volume: 88
  start-page: 121
  year: 2019
  end-page: 127
  ident: bib26
  article-title: Interactions of graphene derivatives with glutamate-neurotransmitter: a parallel first principles-Docking investigation
  publication-title: J. Mol. Graph. Model
  contributor:
    fullname: Fagan
– volume: 2
  year: 2012
  ident: bib27
  article-title: Glutamate mechanisms underlying opiate memories
  publication-title: Cold Spring Harb. Perspec. Med.
  contributor:
    fullname: De
– volume: 277
  start-page: 49
  year: 2015
  end-page: 57
  ident: bib16
  article-title: The role of serotonin in adult hippocampal neurogenesis
  publication-title: Behav. Brain Res.
  contributor:
    fullname: Klempin
– volume: 15
  start-page: 287
  year: 2002
  end-page: 293
  ident: bib51
  article-title: Characterization of the pharmacokinetics of buprenorphine and norbuprenorphine in rats after intravenous bolus administration of buprenorphine
  publication-title: Eur. J. Pharm. Sci.
  contributor:
    fullname: Cowan
– volume: 52
  start-page: 1336
  year: 2007
  end-page: 1341
  ident: bib54
  article-title: The mu opioid receptor is involved in buprenorphine-induced locomotor stimulation and conditioned place preference
  publication-title: Neuropharmacology
  contributor:
    fullname: Lutfy
– volume: 12
  start-page: 2673
  year: 2001
  ident: 10.1016/j.biopha.2021.111515_bib42
  article-title: BDNF induces glutamate release in cerebrocortical nerve terminals and in cortical astrocytes
  publication-title: Neuroreport
  doi: 10.1097/00001756-200108280-00017
  contributor:
    fullname: Pascual
– volume: 57
  start-page: 281
  year: 2011
  ident: 10.1016/j.biopha.2021.111515_bib9
  article-title: Buprenorphine: new treatment of opioid addiction in primary care
  publication-title: Can. Fam. Phys.
  contributor:
    fullname: Kahan
– volume: 6
  year: 2017
  ident: 10.1016/j.biopha.2021.111515_bib21
  article-title: Effects of dopamine on reinforcement learning and consolidation in Parkinson’s disease
  publication-title: Elife
  doi: 10.7554/eLife.26801
  contributor:
    fullname: Grogan
– volume: 33
  start-page: 864
  year: 2009
  ident: 10.1016/j.biopha.2021.111515_bib25
  article-title: The role of glutamate and its receptors in mesocorticolimbic dopaminergic regions in opioid addiction
  publication-title: Neurosci. Biobehav. Rev.
  doi: 10.1016/j.neubiorev.2009.02.005
  contributor:
    fullname: Guo
– volume: 19
  start-page: 212
  year: 1995
  ident: 10.1016/j.biopha.2021.111515_bib29
  article-title: Brain transcription factor gene expression, neurotransmitter levels, and novelty response behaviors: alterations during rat amphetamine withdrawal and following chronic injection stress
  publication-title: Synapse
  doi: 10.1002/syn.890190309
  contributor:
    fullname: Persico
– volume: 8
  start-page: 387
  year: 2018
  ident: 10.1016/j.biopha.2021.111515_bib56
  article-title: Effect of crocin carotenoid on BDNF and CREB gene expression in brain ventral tegmental area of morphine treated rats, Asian Pacific Journal of Tropical Biomedicine
  contributor:
    fullname: Rezai
– volume: 25
  start-page: 1480
  year: 2011
  ident: 10.1016/j.biopha.2021.111515_bib45
  article-title: Serum levels of BDNF are associated with craving in opiate-dependent patients
  publication-title: J. Psychopharmacol.
  doi: 10.1177/0269881111411332
  contributor:
    fullname: Heberlein
– volume: 236
  start-page: 144
  year: 2019
  ident: 10.1016/j.biopha.2021.111515_bib22
  article-title: GABA as a neurotransmitter in Gastropod Molluscs
  publication-title: Biol. Bull.
  doi: 10.1086/701377
  contributor:
    fullname: Miller
– volume: 53
  start-page: 478
  year: 2014
  ident: 10.1016/j.biopha.2021.111515_bib50
  article-title: Pharmacokinetics of sustained-release analgesics in mice
  publication-title: J. Am. Assoc. Lab. Animal Sci.
  contributor:
    fullname: Kendall
– volume: 11
  start-page: 609
  year: 2015
  ident: 10.1016/j.biopha.2021.111515_bib3
  article-title: Buprenorphine, methadone, and morphine treatment during pregnancy: behavioral effects on the offspring in rats
  publication-title: NDT
  doi: 10.2147/NDT.S70585
  contributor:
    fullname: Chen
– volume: 7
  start-page: 514
  year: 2016
  ident: 10.1016/j.biopha.2021.111515_bib15
  article-title: Blockade of serotonin 5-HT2A receptors suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in morphine-treated mice
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2016.00514
  contributor:
    fullname: Pang
– volume: 8
  start-page: 246
  year: 2011
  ident: 10.1016/j.biopha.2021.111515_bib20
  article-title: Dopamine and vascular dynamics control: present status and future perspectives
  publication-title: Curr. Neurovasc. Res.
  doi: 10.2174/156720211796558032
  contributor:
    fullname: Khosrow Tayebati
– volume: 131
  year: 2019
  ident: 10.1016/j.biopha.2021.111515_bib24
  article-title: Activation of MORs in the VTA induces changes on cFos expression in different projecting regions: effect of inflammatory pain
  publication-title: Neurochem. Int.
  doi: 10.1016/j.neuint.2019.104521
  contributor:
    fullname: Campos-Jurado
– volume: 571
  start-page: 61
  year: 2014
  ident: 10.1016/j.biopha.2021.111515_bib40
  article-title: Increased serum brain-derived neurotrophic factor levels during opiate withdrawal
  publication-title: Neurosci. Lett.
  doi: 10.1016/j.neulet.2014.04.048
  contributor:
    fullname: Zhang
– volume: 64
  start-page: 317
  year: 2012
  ident: 10.1016/j.biopha.2021.111515_bib13
  article-title: Understanding the molecular pharmacology of the serotonergic system: using fluoxetine as a model
  publication-title: J. Pharm. Pharmacol.
  doi: 10.1111/j.2042-7158.2011.01384.x
  contributor:
    fullname: Sghendo
– volume: 26
  start-page: 4624
  year: 2006
  ident: 10.1016/j.biopha.2021.111515_bib34
  article-title: Role of cAMP response element-binding protein in the rat locus ceruleus: regulation of neuronal activity and opiate withdrawal behaviors
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.4701-05.2006
  contributor:
    fullname: Han
– volume: 18
  start-page: 415
  year: 2015
  ident: 10.1016/j.biopha.2021.111515_bib47
  article-title: Epigenetic basis of opiate suppression of Bdnf gene expression in the ventral tegmental area
  publication-title: Nat. Neurosci.
  doi: 10.1038/nn.3932
  contributor:
    fullname: Koo
– volume: 10
  start-page: 81
  year: 2005
  ident: 10.1016/j.biopha.2021.111515_bib32
  article-title: Morphine‐induced changes of gene expression in the brain
  publication-title: Addict. Biol.
  doi: 10.1080/13556210412331308994
  contributor:
    fullname: Ammon‐Treiber
– volume: 74
  start-page: 575
  year: 2011
  ident: 10.1016/j.biopha.2021.111515_bib53
  article-title: Simultaneous determination of buprenorphine, norbuprenorphine and naloxone in human plasma by LC-MS-MS
  publication-title: Chromatographia
  doi: 10.1007/s10337-011-2095-2
  contributor:
    fullname: Chiang
– volume: 36
  year: 2018
  ident: 10.1016/j.biopha.2021.111515_bib8
  article-title: Impact of opioid therapy on gonadal hormones: focus on buprenorphine
  publication-title: Horm. Mol. Biol. Clin. Investig.
  contributor:
    fullname: Varma
– volume: 8
  start-page: 859
  year: 2015
  ident: 10.1016/j.biopha.2021.111515_bib5
  article-title: Buprenorphine – an attractive opioid with underutilized potential in treatment of chronic pain
  publication-title: JPR
  contributor:
    fullname: Khanna
– volume: 1395
  start-page: 79
  year: 2015
  ident: 10.1016/j.biopha.2021.111515_bib11
  article-title: Simultaneous analysis of multiple neurotransmitters by hydrophilic interaction liquid chromatography coupled to tandem mass spectrometry
  publication-title: J. Chromatogr. A
  doi: 10.1016/j.chroma.2015.03.056
  contributor:
    fullname: Tufi
– volume: 28
  start-page: 436
  year: 2005
  ident: 10.1016/j.biopha.2021.111515_bib30
  article-title: The many faces of CREB
  publication-title: Trends Neurosci.
  doi: 10.1016/j.tins.2005.06.005
  contributor:
    fullname: Carlezon
– volume: 1
  start-page: 13
  year: 2002
  ident: 10.1016/j.biopha.2021.111515_bib28
  article-title: The neurobiology of opioid dependence: implications for treatment
  publication-title: Sci. Prac. Perspec.
  doi: 10.1151/spp021113
  contributor:
    fullname: Kosten
– volume: 28
  start-page: 233
  year: 2019
  ident: 10.1016/j.biopha.2021.111515_bib4
  article-title: Historical review: opiate addiction and opioid receptors
  publication-title: Cell Transplant
  doi: 10.1177/0963689718811060
  contributor:
    fullname: Wang
– volume: 198
  start-page: 187
  year: 2011
  ident: 10.1016/j.biopha.2021.111515_bib12
  article-title: Development and validation of an ultra-high performance liquid chromatography–tandem mass-spectrometry (UHPLC–MS/MS) method for the simultaneous determination of neurotransmitters in rat brain samples
  publication-title: J. Neurosci. Methods
  doi: 10.1016/j.jneumeth.2011.03.023
  contributor:
    fullname: González
– volume: 13
  start-page: 997
  year: 2018
  ident: 10.1016/j.biopha.2021.111515_bib48
  article-title: Enhanced brain penetration of pretomanid by intranasal administration of an oil-in-water nanoemulsion
  publication-title: Nanomedicine
  doi: 10.2217/nnm-2017-0365
  contributor:
    fullname: Shobo
– volume: 277
  start-page: 49
  year: 2015
  ident: 10.1016/j.biopha.2021.111515_bib16
  article-title: The role of serotonin in adult hippocampal neurogenesis
  publication-title: Behav. Brain Res.
  doi: 10.1016/j.bbr.2014.07.038
  contributor:
    fullname: Alenina
– volume: 61
  start-page: 101
  year: 2007
  ident: 10.1016/j.biopha.2021.111515_bib7
  article-title: Buprenorphine duration of action: mu-opioid receptor availability and pharmacokinetic and behavioral indices
  publication-title: Biol. Psychiatry
  doi: 10.1016/j.biopsych.2006.04.043
  contributor:
    fullname: Greenwald
– volume: 67
  start-page: 451
  year: 2015
  ident: 10.1016/j.biopha.2021.111515_bib18
  article-title: Context-controlled nicotine-induced changes in the labeling of serotonin (5-HT) 2A and 5-HT2C receptors in the rat brain
  publication-title: Pharmacol. Rep.
  doi: 10.1016/j.pharep.2014.11.002
  contributor:
    fullname: Zaniewska
– volume: 124
  start-page: 52
  year: 2017
  ident: 10.1016/j.biopha.2021.111515_bib19
  article-title: Endocannabinoid modulation of dopamine neurotransmission
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2017.04.033
  contributor:
    fullname: Covey
– volume: 29
  start-page: 1122
  year: 2004
  ident: 10.1016/j.biopha.2021.111515_bib31
  article-title: Modulation of anxiety-like behavior and morphine dependence in CREB-deficient mice
  publication-title: Neuropsychopharmacology
  doi: 10.1038/sj.npp.1300416
  contributor:
    fullname: Valverde
– volume: 88
  start-page: 121
  year: 2019
  ident: 10.1016/j.biopha.2021.111515_bib26
  article-title: Interactions of graphene derivatives with glutamate-neurotransmitter: a parallel first principles-Docking investigation
  publication-title: J. Mol. Graph. Model
  doi: 10.1016/j.jmgm.2019.01.007
  contributor:
    fullname: Tonel
– volume: 4
  start-page: 14
  year: 2011
  ident: 10.1016/j.biopha.2021.111515_bib41
  article-title: Cooperation between BDNF and glutamate in the regulation of synaptic transmission and neuronal development
  publication-title: Commun. Integr. Biol.
  doi: 10.4161/cib.13761
  contributor:
    fullname: Martin
– volume: 8
  year: 2013
  ident: 10.1016/j.biopha.2021.111515_bib36
  article-title: Dopamine modulates acetylcholine release via octopamine and CREB signaling in Caenorhabditis elegans
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0072578
  contributor:
    fullname: Suo
– volume: 135
  start-page: 2286
  year: 2010
  ident: 10.1016/j.biopha.2021.111515_bib14
  article-title: Selective detection of neurotransmitter serotonin by a gold nanoparticle-modified glassy carbon electrode
  publication-title: Analyst
  doi: 10.1039/c0an00256a
  contributor:
    fullname: Wei
– volume: 101
  start-page: 246
  year: 2016
  ident: 10.1016/j.biopha.2021.111515_bib17
  article-title: Activation of serotonin 5-HT2C receptor suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in morphine-dependent mice
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2015.09.031
  contributor:
    fullname: Zhang
– volume: 28
  start-page: 499
  year: 2017
  ident: 10.1016/j.biopha.2021.111515_bib38
  article-title: Peripheral levels of BDNF and opiate-use disorder: literature review and update
  publication-title: Rev. Neurosci.
  doi: 10.1515/revneuro-2016-0078
  contributor:
    fullname: Palma-Álvarez
– volume: 15
  start-page: 287
  year: 2002
  ident: 10.1016/j.biopha.2021.111515_bib51
  article-title: Characterization of the pharmacokinetics of buprenorphine and norbuprenorphine in rats after intravenous bolus administration of buprenorphine
  publication-title: Eur. J. Pharm. Sci.
  doi: 10.1016/S0928-0987(02)00009-X
  contributor:
    fullname: Gopal
– volume: 21
  start-page: 820
  year: 2007
  ident: 10.1016/j.biopha.2021.111515_bib44
  article-title: Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factor
  publication-title: J. Psychopharmacol.
  doi: 10.1177/0269881107078491
  contributor:
    fullname: Angelucci
– start-page: 59
  year: 2016
  ident: 10.1016/j.biopha.2021.111515_bib1
  article-title: Quantitation of total buprenorphine and norbuprenorphine in meconium by LC-MS/MS
  contributor:
    fullname: Marin
– volume: 140
  start-page: 86
  year: 2005
  ident: 10.1016/j.biopha.2021.111515_bib37
  article-title: Brain-derived neurotrophic factor (Val66Met) genetic polymorphism is associated with substance abuse in males
  publication-title: Mol. Brain Res.
  doi: 10.1016/j.molbrainres.2005.07.008
  contributor:
    fullname: Cheng
– volume: 338
  start-page: 124
  year: 2012
  ident: 10.1016/j.biopha.2021.111515_bib23
  article-title: BDNF is a negative modulator of morphine action
  publication-title: Science
  doi: 10.1126/science.1222265
  contributor:
    fullname: Koo
– volume: 39
  start-page: 619
  year: 1999
  ident: 10.1016/j.biopha.2021.111515_bib2
  article-title: Buprenorphine pharmacokinetics: relative bioavailability of sublingual tablet and liquid formulations
  publication-title: The Journal of Clinical Pharmacology
  doi: 10.1177/00912709922008236
  contributor:
    fullname: Nath
– volume: 106
  start-page: 1460
  year: 2011
  ident: 10.1016/j.biopha.2021.111515_bib52
  article-title: The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2011.03424.x
  contributor:
    fullname: Middleton
– volume: 52
  start-page: 1336
  year: 2007
  ident: 10.1016/j.biopha.2021.111515_bib54
  article-title: The mu opioid receptor is involved in buprenorphine-induced locomotor stimulation and conditioned place preference
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2007.01.005
  contributor:
    fullname: Marquez
– volume: 116
  start-page: 1
  year: 2011
  ident: 10.1016/j.biopha.2021.111515_bib33
  article-title: CREB: a multifaceted regulator of neuronal plasticity and protection
  publication-title: J. Neurochem.
  doi: 10.1111/j.1471-4159.2010.07080.x
  contributor:
    fullname: Sakamoto
– volume: 44
  start-page: 2139
  year: 2019
  ident: 10.1016/j.biopha.2021.111515_bib46
  article-title: and Arc mRNA expression in the hippocampus of rats after administration of morphine
  publication-title: Neurochem. Res.
  doi: 10.1007/s11064-019-02851-z
  contributor:
    fullname: Rouhani
– volume: 12
  start-page: 273
  year: 2018
  ident: 10.1016/j.biopha.2021.111515_bib39
  article-title: Mechanism of BDNF modulation in GABAergic synaptic transmission in healthy and disease brains
  publication-title: Front. Cell. Neurosci.
  doi: 10.3389/fncel.2018.00273
  contributor:
    fullname: Porcher
– volume: 64
  start-page: 1709
  year: 2012
  ident: 10.1016/j.biopha.2021.111515_bib55
  article-title: Intranasal delivery of insulin via the olfactory nerve pathway
  publication-title: J. Pharm. Pharmacol.
  doi: 10.1111/j.2042-7158.2012.01555.x
  contributor:
    fullname: Renner
– volume: 78
  start-page: 1211
  year: 2018
  ident: 10.1016/j.biopha.2021.111515_bib10
  article-title: Treating chronic pain: an overview of clinical studies centered on the buprenorphine option
  publication-title: Drugs
  doi: 10.1007/s40265-018-0953-z
  contributor:
    fullname: Davis
– volume: 19
  start-page: 675
  year: 2018
  ident: 10.1016/j.biopha.2021.111515_bib6
  article-title: Single high-dose buprenorphine for opioid craving during withdrawal
  publication-title: Trials
  doi: 10.1186/s13063-018-3055-z
  contributor:
    fullname: Ahmadi
– volume: 2
  year: 2012
  ident: 10.1016/j.biopha.2021.111515_bib27
  article-title: Glutamate mechanisms underlying opiate memories
  publication-title: Cold Spring Harb. Perspec. Med.
  doi: 10.1101/cshperspect.a012088
  contributor:
    fullname: Peters
– volume: 25
  start-page: 402
  year: 2001
  ident: 10.1016/j.biopha.2021.111515_bib49
  article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method
  publication-title: Methods
  doi: 10.1006/meth.2001.1262
  contributor:
    fullname: Livak
– volume: 60
  start-page: 557
  year: 2000
  ident: 10.1016/j.biopha.2021.111515_bib35
  article-title: Effect of opioids on Ca2+/cAMP responsive element binding protein
  publication-title: Acta Neurobiol. Exp.
  doi: 10.55782/ane-2000-1376
  contributor:
    fullname: Bilecki
– volume: 65
  start-page: 150
  year: 2016
  ident: 10.1016/j.biopha.2021.111515_bib43
  article-title: Brain-derived neurotrophic factor serum levels in heroin-dependent patients after 26 weeks of withdrawal
  publication-title: Compr. Psychiatry
  doi: 10.1016/j.comppsych.2015.11.010
  contributor:
    fullname: Zhang
SSID ssj0005638
Score 2.365105
Snippet Buprenorphine is an opioid drug used in the management of pain and the treatment opioid addiction. Like other opioids, it is believed that it achieves these...
SourceID doaj
proquest
crossref
pubmed
elsevier
SourceType Open Website
Aggregation Database
Index Database
Publisher
StartPage 111515
SubjectTerms Administration, Intranasal - methods
Analgesics, Opioid - administration & dosage
Animals
Brain - drug effects
Brain - metabolism
Brain-derived neurotrophic factor (BDNF)
Brain-Derived Neurotrophic Factor - biosynthesis
Brain-Derived Neurotrophic Factor - genetics
Buprenorphine
Buprenorphine - administration & dosage
Cyclic AMP response element-binding protein (CREB)
Cyclic AMP Response Element-Binding Protein - biosynthesis
Cyclic AMP Response Element-Binding Protein - genetics
Gene Expression
Male
Neurotransmitter Agents - biosynthesis
Neurotransmitter Agents - genetics
Neurotransmitters
Opioid addiction
Rats
Rats, Sprague-Dawley
Transcription Factors - biosynthesis
Transcription Factors - genetics
SummonAdditionalLinks – databaseName: ScienceDirect Freedom Collection Journals
  dbid: AIKHN
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZhA6WX0qav7QsVSk4Ra1vy67gNDduWhEATyE3oWVxSO2R3SQL98Z2R5Gz3UAoFXyxkWWhG843QzDeEfLC2NQYMH1NN2TBRWcsUoCYD9LNGlVYUGpOTj0-qxbn4clFe7JDDMRcGwyqT7Y82PVjr1DJLqzm76rrZNwA7zvGiIEdNzeDcvgtwJMSE7M4_f12cbCI9qlDQGvsz_GDMoAthXrobkJepAKxD81Fifdw_ECoQ-W8B1d8c0QBIR4_Jo-RJ0nmc7BOy4_o98uA43ZXvkf3TyEp9d0DPNklWywO6T083fNV3T8mv-WWgVkYFpF1PA8XlCjHsZ4e5PvQSA4uWVPWWhubR0NBYrIe62xRNCy2gVsMNwCEMhH3VEqao10icOYBEYWJUbdH1PiPnR5_ODhcsFWVgRtRixUrFFTy1KrJKc_C2TJNppz2sXMO1yHWlREinhaOS5hXIm-fK5j5vVevy2vDnZNIPvXtJqPBKe8F9LZwFe63hKGjAwWoz77gr2mZK2CgIeRW5N-QYlPZDRsFJFJyMgpuSjyit-77InB0ahuvvMqmO1KIwrVeNQ6rCypeNA53UmfKmAGer9lNSj7KWW4oIQ3X_-P37UTUk7FG8eFG9G9ZLGWjiBJYJm5IXUWfuJ8l5XcJSFq_--7-vyUN8i_Frb8hkdb12b8FTWul3aSf8BiiKFP8
  priority: 102
  providerName: Elsevier
Title Alterations in neurotransmitter levels and transcription factor expression following intranasal buprenorphine administration
URI https://dx.doi.org/10.1016/j.biopha.2021.111515
https://www.ncbi.nlm.nih.gov/pubmed/33752062
https://search.proquest.com/docview/2504340297
https://doaj.org/article/b42c9fa8e37146f58edcab0afc27107f
Volume 138
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LaxRBEC40gngRja-NurQgOaV1Z7rndVyDYVWy5pDA4qXpJ2yIM5LdRQPib7eqeyaPg-QizGWapqfoqqmvmq76CuCtc4216Pi4rouay9I5rhE1OaKfs7pwMjdUnHw4L2cn8vOiWFxr9UU5YYkeOG3ceyNz2wRde6KWK0NRe1zDTHSwOYJjFaL3zYrhMDUkd5SxhzXioeACbXYomouZXWbZERUTHvsz8hgFtcS9BkqRu_8GNv0r9owYdPAIHvbBI5smoR_DHd9uw_3D_np8G3aPEhH1xR47vqqrWu2xXXZ0RVF98QR-T88imzLZHFu2LLJargm2vi-pvIedUS7RiunWsTg8-BaW-vMw_6tPoMURtKTuJyIgLkRz9QpFNBviyuxQiSgY0zcYep_CycHH4_0Z7_swcCsrueaFFhqfSueT0ggMsGw9Md4E3LlaGJmZUstYQYunIyNKVLHItMtC1ujGZ5UVz2Cr7Vr_ApgM2gQpQiW9Qxdt8PRnMaZqJsELnzf1CPigCPUj0W2oIQ_tVCXFKVKcSoobwQfS1uVcIsuOA2hCqjchdZsJjaAadK36uCPFE7jU8pbPvxlMQ-FvSXctuvXdZqUiM5ykzmAjeJ5s5lJIIaoCtzLf-R_Cv4QHJFDKXnsFW-vzjX-NcdLajOHuuz_ZGO5NP32ZzcfxB8G3-f7i67e_hVkYSQ
link.rule.ids 315,786,790,870,2115,4521,24144,27955,27956,45618,45712
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dSxwxEA9ioe2LtPbr7FcKxSfT291kvx6tVK6tJ0JP8C3ks6zornh3tELxb3cm2VXvoRQK-5QNSchM5jchM78h5KO1tTFg-Jiq8oqJwlqmADUZoJ81Krci05icPD0sJsfi20l-skb2hlwYDKvsbX-06cFa9y3jfjfHF00z_gFgxzk-FKSoqQnc2x-gN4BxXZ-u78V5FKGcNfZm2H3InwtBXrrpkJUpA6RD45Fjddx7-BRo_Fdg6m9uaICj_Sdko_cj6W5c6lOy5tpN8nDav5Rvku2jyEl9tUNndylW8x26TY_u2KqvnpE_u2eBWBnVjzYtDQSXC0Sw8wYzfegZhhXNqWotDc2DmaGxVA91v_tYWmgBpep-ARjCQNhXzWGJeom0mR3IExZG1QpZ73NyvP9ltjdhfUkGZkQpFixXXMFXqiwpNAdfy1SJdtrDzlVci1QXSoRkWrgoaV6AtHmqbOrTWtUuLQ1_QdbbrnWvCBVeaS-4L4WzYK01XAQNuFd14h13WV2NCBsEIS8i84YcQtJOZRScRMHJKLgR-YzSuu2LvNmhobv8KXvFkVpkpvaqckhUWPi8cqCROlHeZOBqlX5EykHWckUNYajmH9N_GFRDwgnFZxfVum45l4EkTmCRsBF5GXXmdpGclzlsZbb13_O-J48ms-mBPPh6-P01eYx_YiTbG7K-uFy6t-AzLfS7cCZuACpwFtI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Alterations+in+neurotransmitter+levels+and+transcription+factor+expression+following+intranasal+buprenorphine+administration&rft.jtitle=Biomedicine+%26+pharmacotherapy&rft.au=Xhakaza%2C+Sanelisiwe+P.&rft.au=Khoza%2C+Leon+J.&rft.au=Haripershad%2C+Advaitaa+M.&rft.au=Ghazi%2C+Terisha&rft.date=2021-06-01&rft.issn=0753-3322&rft.volume=138&rft.spage=111515&rft_id=info:doi/10.1016%2Fj.biopha.2021.111515&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_biopha_2021_111515
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0753-3322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0753-3322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0753-3322&client=summon